Quarter-over-quarter and year-over-year time series from SEC company facts — every whitelisted metric with deltas, ratios, and anomaly flags.
Coverage
25 of 25 metrics reported
Selected
$11.28B
2026-04-03 · quarterly · YoY 130.1%
| Period end | Frequency | Value | QoQ | YoY | Flag |
|---|---|---|---|---|---|
| 2026-04-03 | quarterly | $11.28B | +111.6% | +130.1% | Anomaly |
| 2026-01-02 | quarterly | $5.33B | +131.1% | +66.8% | Anomaly |
| 2025-10-03 | quarterly | $2.31B | -57.7% | — | |
| 2025-03-28 | quarterly | $5.45B | +45.1% | +11.2% | |
| 2024-12-27 | quarterly | $3.76B | +99.6% | +17.5% | |
| 2024-09-27 | quarterly | $1.88B | -61.6% | — | |
| 2024-03-29 | quarterly | $4.90B | +53.3% | — | |
| 2023-12-29 | quarterly | $3.20B | — | — |
revenue · magnitude 131.1%
revenue · magnitude 111.6%
| Metric | Status | Annual | Quarterly | Gaps |
|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | reported | 3 | 8 | 1 |
| Cost Of Goods And Services Sold | reported | 3 | 8 | 1 |
| Gross Profit | reported | 3 | 8 | 1 |
| Research And Development Expense | reported | 3 | 8 | 1 |
| Selling General And Administrative Expense | reported | 3 | 8 | 1 |
| Operating Income Loss | reported | 3 | 8 | 1 |
| Net Income Loss | reported | 3 | 9 | 3 |
| EPS Basic | reported | 3 | 7 | 1 |
| EPS Diluted | reported | 3 | 7 | 1 |
| Cash And Cash Equivalents At Carrying Value | reported | 2 | 7 | 3 |
| Accounts Receivable Net Current | reported | 2 | 7 | 3 |
| Inventory Net | reported | 2 | 7 | 3 |
| Assets Current | reported | 2 | 7 | 3 |
| Assets | reported | 2 | 7 | 3 |
| Liabilities Current | reported | 2 | 7 | 3 |
| Long Term Debt Non-current | reported | 2 | 6 | 3 |
| Liabilities | reported | 2 | 7 | 3 |
| Stockholders Equity | reported | 4 | 12 | 3 |
| Net Cash Provided By Used In Operating Activities | reported | 3 | 8 | 1 |
| Net Cash Provided By Used In Investing Activities | reported | 3 | 8 | 1 |
| Net Cash Provided By Used In Financing Activities | reported | 3 | 8 | 1 |
| Entity Common Stock Shares Outstanding | reported | 1 | 5 | 1 |
| Weighted Average Number Of Shares Outstanding Basic | reported | 3 | 7 | 1 |
| Weighted Average Number Of Diluted Shares Outstanding | reported | 3 | 7 | 1 |
| Common Stock Shares Authorized | reported | 1 | 5 | 3 |